98%
921
2 minutes
20
Objectives: This study aimed to develop and validate a nomogram based on extracellular volume (ECV) derived from computed tomography (CT) for predicting post-hepatectomy liver failure (PHLF) in patients with resectable hepatocellular carcinoma (HCC).
Methods: A total of 202 patients with resectable HCC from two hospitals were enrolled and underwent multiphasic contrast-enhanced CT before surgery. One hundred twenty-one patients from our hospital and 81 patients from another hospital were assigned to the training cohort and the validation cohort, respectively. CT-derived ECV was measured using nonenhanced and equilibrium-phase-enhanced CT images. The nomogram was developed with independent predictors of PHLF. Predictive performance and calibration were assessed by receiver operator characteristic (ROC) analysis and Hosmer-Lemeshow test, respectively. The Delong test was used to compare the areas under the curve (AUCs).
Results: CT-derived ECV had a strong correlation with the postoperative pathological fibrosis stage of the background liver (p < 0.001, r = 0.591). The nomogram combining CT-derived ECV, serum albumin (Alb), and serum total bilirubin (Tbil) obtained higher AUCs than the albumin-bilirubin (ALBI) score for predicting PHLF in both the training cohort (0.828 vs. 0.708; p = 0.004) and the validation cohort (0.821 vs. 0.630; p < 0.001). The nomogram showed satisfactory goodness of fit for PHLF prediction in the training and validation cohorts (p = 0.621 and 0.697, respectively).
Conclusions: The nomogram contributes to the preoperative prediction of PHLF in patients with resectable HCC.
Key Points: • CT-derived ECV had a strong correlation with the postoperative pathological fibrosis stage of the background liver. • CT-derived ECV was an independent predictor of PHLF in patients with resectable HCC. • The nomogram based on CT-derived ECV showed a superior prediction efficacy than that of clinical models (including Child-Pugh stage, MELD score, and ALBI score).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00330-022-08917-x | DOI Listing |
Eur J Radiol
August 2025
Department of Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. No.197 Ruijin Er Road Shanghai, Shanghai CN200025, China. Electronic address:
Rationale And Objectives: Advances in computed tomography (CT) have enabled myocardial extracellular volume (ECV) quantification, but the optimal post-contrast timing for CT-derived ECV remains undefined. In this preclinical study using a swine model, we aimed to determine the optimal post-contrast acquisition time for photon-counting CT (PCCT)-derived ECV using cardiac magnetic resonance (CMR) as the reference standard.
Materials And Methods: Twenty-three CMR and PCCT scans were performed on infarcted swine, and nine scans on healthy controls.
Eur J Radiol
August 2025
Department of Radiology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China. Electronic address:
Background: Prostate cancer (PCa) patients with androgen deprivation therapy (ADT) are at high risk for cardiotoxicity and major adverse cardiovascular events (MACE). It is unclear whether the myocardial extracellular volume (ECV) derived from chest contrast-enhanced CT (CECT) can detect cardiotoxicity and predict MACE in these patients. This work aimed to assess the value of chest CECT derived myocardial ECV for detecting cardiotoxicity and the association of ECV with MACE in PCa patients receiving ADT.
View Article and Find Full Text PDFMedicine (Baltimore)
August 2025
Department of General Surgery, Beijing Anzhen Nanchong Hospital of Capital Medical University & Nanchong Central Hospital, Nanchong, Sichuan Province, China.
This study evaluates the association between computed tomography-derived extracellular volume fraction (CT-ECV), serological markers, and histological grading in colorectal cancer, and to assess their diagnostic value in predicting poorly differentiated tumors. This retrospective study included 200 patients with pathologically confirmed primary colorectal cancer from February 2021 to May 2024. All underwent dual-phase contrast-enhanced CT and serological testing before treatment.
View Article and Find Full Text PDFAcad Radiol
August 2025
Department of Radiology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China (Y.G., Q.F., Y.L., D.Y., L.C., G.B.); Key Laboratory of Structural Malformations in Children of Zhejiang Province, Wenzhou, Zhejiang Province, China
Rationale And Objectives: We developed a machine learning model comprising morphological characteristics, enhancement dynamics, and extracellular volume (ECV) fractions for distinguishing malignant and benign small renal masses (SRMs), supporting personalised management.
Materials And Methods: This retrospective analysis involved 230 patients who underwent SRM resection with preoperative imaging, including 185 internal and 45 external cases. The internal cohort was split into training (n=136) and validation (n=49) sets.
Abdom Radiol (NY)
July 2025
Lanzhou University Second Hospital, Lanzhou, China.
Objectives: This study aimed to investigate the value of contrast-enhanced computed tomography (CECT)-derived extracellular volume (ECV) fraction for preoperative evaluation of tumor-stroma ratio (TSR) in colorectal cancer (CRC).
Materials And Methods: We retrospectively analyzed CRC patients who underwent CECT between July 2021 and July 2023. Patients were randomly allocated into a training cohort (n = 188) and a validation cohort (n = 78).